Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4297-4300

  Taniguchi, Masahiko ^a   Nishida, Toshirou ^a   Hirota, Seiichi ^a   Isozaki, Koji ^a   Ito, Toshinori ^a   Nomura, Taisei ^a   Matsuda, Hikaru ^a   Kitamura, Yukihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; DNA SEQUENCE; FEMALE; GASTROINTESTINAL TUMOR; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MESENCHYME; ONCOGENE C KIT; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STROMA CELL;

EID: 0033199890     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fishman, A. P. Gastrointestinal tract. In: J. Rosai (ed.), Ackerman's Surgical Pathology, Ed. 8, pp. 691-693. St. Louis: Mosby, 1996.
2. Hirota, S., Isozaki, K., Moriyama, Y., Kanakura, Y., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Tunio, G. M., Matsuzawa, Y., Shinomura, Y., and Kitamura, Y. Gain-of-function mutation of c-kit in human gastrointestinal stromal tumors. Science (Washington DC), 279: 577-580, 1998.
3. van de Rijn, M., Hendrickson, M. R., and Rouse, R. V. CD34 expression by gastrointestinal tract stroma tumors. Hum. Pathol., 25: 766-771, 1994.
4. Kindblom, L. G., Remotti, H. E., Aldenborg, F., and Meis-Kindblom, J. M. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol., 152: 1259-1269, 1998.
5. Maeda, H., Yamagata, A., Nishikawa, S., Yoshinaga, K., Kobayashi, S., Nishi, K., and Nishikawa, S. I. Requirement of c-kit for development of intestinal pacemaker system. Development (Camb.), 116: 369-375, 1992.
6. Huizinga, J. D., Thuneberg, L., Klüppel, M., Malysz, J., Mikkelsen, H. B., and Bernstein, A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature (Lond.), 373: 347-349, 1995.
7. Ward, S. M., Burns, A. J., Torihashi, S., and Sanders, K. M. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. J. Physiol., 480: 91-97, 1994.
8. Isozaki, K., Hirota, S., Nakama, A., Miyagawa, J., Shinomura, Y., Xu, Z., Nomura, S., and Kitamura, Y. Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats. Gastroenterology, 109: 456-464, 1995.
9. Besmer, P., Murphy, J. E., George, P. C., Qiu, F. H., Bergold, P. J., Lederman, L., Snyder, H. W., Jr., Broudeur, D., Zuckerman, E. E., and Hardy, W. D. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (Lond.), 520: 415-421, 1986.
10. Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., and Ullrich, A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J., 6:3341-3351, 1988.
11. Qiu, F. H., Ray, P., Brown, K., Barker, P. E., Jhanwar, S., Ruddle, F. H., and Besmer, P. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J., 7: 1003-1011, 1988.
12. Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., Kanayama, Y., Matsuzawa, Y., Kitamura, Y., and Kanakura, Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J. Clin. Invest., 92: 1736-1744, 1993.
13. Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., and Metcalfe, D. D. Identification of a point mutation in the catalytic domain of the protooncogene c-kil in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. USA, 92: 10560-10564, 1995.
14. Longley, B. J., Tyrrell, L., Lu, S. Z., Ma, Y. S., Langley, K., Ding, T. G., Duffy, T., Jacobs, P., Tang, L. H., and Modlin, I. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat. Genet., 12: 312-314, 1996.
15. Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H., and Kitamura, Y. Familial gastrointestinal stromal tumors with germ line mutation of the KIT gene. Nat. Genet., 19: 323-324, 1998.
16. Morgan, B. K., Compton, C., Talbert, M., Gallagher, W. J., and Wood, W. C. Benign smooth muscle tumors of the gastrointestinal tract: a 24-year experience. Ann. Surg., 211: 63-66, 1990.
17. Chou, F-F., Eng, H. L., and Sheen-Chen, S. M. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors. Surgery (St. Louis), 119: 171-177, 1996.
18. Shiu, M. H., Farr, G. H., Papachristou, D. N., and Hajdu, S. I. Myosarcomas of the stomach: natural history, prognostic factors and managements. Cancer (Phila.), 49: 177-187, 1982.
19. Ng, E. H., Pollock, R. E., Munsell, M. F., Atkinson, E. N., and Romsdahl, M. M. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann. Surg., 215: 68-77, 1992.
20. Franquemont, D. W. Differentiation and risk assessment of gastrointestinal stromal tumors. Am. J. Clin. Pathol., 103: 41-47, 1995.
21. Miettinen, M., Virolainen, M., and Sarlomo-Rikala, M. Gastrointestinal stromal tumors: value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am. J. Surg. Pathol., 19: 207-216, 1995.
22. Kenneth, P. B., and Kenneth, W. B. The esophagus and stomach. In: N. Weidner (ed.), The Difficult Diagnosis in Surgical Pathology, pp. 198-200. Philadelphia: W. B. Saunders, 1996.
23. Hongyo, T., Buzard, G., Calvert, R., and Weghorst G. "Cold-SSCP": a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acid Res., 21: 3637-3642, 1993.
24. Giebel, L. B., Strunk, K. M., Holmes, S. A., and Spritz, R. A. Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene, 7: 2207-2217, 1992.
25. Fuller, C. E., and Williams, G. T. Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology, 19: 1-11, 1991.
26. Ishida, T., Wada, I., Horiuchi, H., Oka, T., and Machinami, R. Multiple small intestinal stromal tumors with skeinoid fibers in association with neurofibromatosis 1 (von Recklinghausen's disease). Pathol. Int., 46: 689-695, 1996.
27. Moskaluk, C. A., Tian, Q., Marshall, C. R., Rumpel, C. A., Franquemont, D. W., and Frieson, H. F., Jr. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene, 18: 1897-1902, 1999.
28. Lasota, J., Jasinski, M., Sarlomo-Rikala, M., and Miettinen, M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol., 154: 53-60, 1999.
29. Nakahara, M., Isozaki, K., Hirota, S., Miyagawa, J., Hase-Sawada, N., Taniguchi, M., Nishida, T., Kanayama, S., Kitamura, Y., Shinomura, Y., and Matsuzawa, Y. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology, 115: 1090-1095, 1998.